Together, these data suggest that relacorilant-mediated upregulation of SSTR2 provides more targets for somatostatin and somatostatin analogs, which can lead to tumor shrinkage in ACTH-secreting pituitary tumors. The gene discussed is POMC; the disease is pituitary tumor.